跳至主要内容
临床试验/NCT05702255
NCT05702255已完成不适用

Effect of Self- Administered Acupressure on Diarrhea Predominant Irritable Bowel Syndrome Patients' Health Outcomes: a Double Blind- Sham Controlled Randomized Clinical Trial

Alexandria University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2023年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Change from the baseline irritable Bowel Syndrome Symptom Severity Score at 2 weeks

研究概览

简要总结

This study aims to assess the effect of active self- administered acupressure compared to sham self- administered acupressure on the health outcome for patient with diarrhea predominant Irritable Bowel Syndrome

详细描述

Research suggests promising benefits of acupuncture in terms of symptom control and quality of life improvements in patients with irritable bowel syndrome. but the cost of the needle and the invasive nature of the procedure decreases patient compliance with acupuncture. in this respect, acupressure can be taught to patients to allow them to perform it themselves, instead of being administered by practitioners. Self-administered acupressure is less time-intensive, low-cost, and flexible to perform. Nurses involved in irritable bowel syndrome patient care play an active role in the practitioner-patient relationship By assessing the specific symptoms that are present, determining the severity of symptoms and the impact on the irritable bowel syndrome patient's life, and being knowledgeable of available treatment options, the nurse involved in irritable bowel syndrome care becomes an essential conduit of information and a valuable facilitator of a positive practitioner-patient therapeutic relationship. In this way, nurses can help to limit the negative consequences of this common disorder and improve overall treatment outcomes in this population. . Thus this study will be conducted to assess the effectiveness of active self-administered acupressure on diarrhea-predominant irritable bowel syndrome

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

盲法说明

a randomization sequence will be generated by an independent statistician. The randomization list will be recorded and enclosed in sequentially numbered, opaque envelopes. after finishing baseline assessment, the training researcher will open the envelopes to avoid selection bias. only the training researcher will know the group allocation. Participants and other relevant researchers (the outcome evaluator, data managers, and statisticians) will be blinded to the group allocation.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with diarrhea irritable bowel syndrome symptoms following Rome IV diagnostic criteria
  • Agreed to be on a fixed dose of the pharmacological therapy throughout the study

排除标准

  • Patients with severe lesions in major organs such as the heart, liver, and kidney, hematopoietic diseases, or tumors
  • Eating disorders
  • History of major abdominal surgery
  • History of neurological and mental illness
  • Usage of other treatment rather than the medical treatment regularly 2 weeks before randomization and throughout the study
  • Previous history of drug or alcohol abuse 6 months before randomization
  • Pregnant and lactating women.
  • Patient reporting of adequate relief of their irritable bowel syndrome symptoms the week preceding the randomization
  • Patient has too mild symptoms ( obtaining less than 75 on Irritable bowel syndrome symptoms severity scale at the baseline assessment)
  • Currently participating in other clinical trials

结局指标

主要结局

Change from the baseline irritable Bowel Syndrome Symptom Severity Score at 2 weeks

时间窗: after 2 weeks from the baseline

t is five item questionnaire measuring frequency and intensity of abdominal pain, the severity of abdominal distension, dissatisfaction with bowel habits, and the interference of IBS with daily life. Subjects respond to each question on a 100-point visual analogue scale. The total score ranges from 0 to 500. Subjects can be categorized as having mild (75-175), moderate (175-300), or severe (\>300) disease

Change from the baseline irritable Bowel Syndrome Symptom Severity Score at 4 weeks

时间窗: after 4 weeks from the baseline

t is five item questionnaire measuring frequency and intensity of abdominal pain, the severity of abdominal distension, dissatisfaction with bowel habits, and the interference of IBS with daily life. Subjects respond to each question on a 100-point visual analogue scale. The total score ranges from 0 to 500. Subjects can be categorized as having mild (75-175), moderate (175-300), or severe (\>300) disease

Change in the frequency of stool consistency at 2 weeks from the baseline

时间窗: after 2 weeks from baseline

defined by the Bristol Stool Form Scale

Baseline mean of irritable Bowel Syndrome Symptom Severity Score

时间窗: Immediately before assigning the participants to the study groups

It is five item questionnaire measuring frequency and intensity of abdominal pain, the severity of abdominal distension, dissatisfaction with bowel habits, and the interference of IBS with daily life. Subjects respond to each question on a 100-point visual analogue scale. The total score ranges from 0 to 500. Subjects can be categorized as having mild (75-175), moderate (175-300), or severe (\>300) disease

Change in the frequency of stool consistency at 4 weeks from the baseline

时间窗: after 4 weeks

Defined by the Bristol Stool Form Scale, It is an ordinal scale of stool types ranging from the hardest (Type 1) to the softest (Type 7). Types 1 and2 are considered to be abnormally hard stools while Types 6 and 7 are considered abnormally loose/liquid stools. Type 3, 4 and 5 are considered to be the most normal stool type

Irritable Bowel Syndrome Adequate Relief question

时间窗: After 4 weeks from the baseline

It is a dichotomous single item that asks participants "Over the past week have you had adequate relief of your irritable Bowel Syndrome symptoms?" . A responder was defined as a patient who answered this question affirmatively.

Mean stool frequency after 2 weeks

时间窗: After 2 weeks from the patient endorsement

Defined by the bi-weekly change of frequency of defecation,patient will report the number of defecation per day to calculate it.

Mean change of stool frequency after 4 weeks

时间窗: After 4 weeks from the patient endorsement

Defined by the bi-weekly change of frequency of defecation,patient will report the number of defecation per day to calculate it.

Stool consistency

时间窗: at the baseline

Defined by the Bristol Stool Form Scale, It is an ordinal scale of stool types ranging from the hardest (Type 1) to the softest (Type 7). Types 1 and2 are considered to be abnormally hard stools while Types 6 and 7 are considered abnormally loose/liquid stools. Type 3, 4 and 5 are considered to be the most normal stool type

次要结局

  • Demographic and clinical data(before assignment of the participants to the study groups)
  • Baseline mean of the quality of Life(at the baseline)
  • Change from the baseline mean of the quality of life at 4 weeks(Four weeks after the baseline assessment)
  • Related adverse Events(from the patients endorsement till one week after study completion)
  • use of rescue medicine(throughout study completion, an average of 4 months)
  • the baseline mean of psychological distress measured by the Hospital Anxiety and Depression Scale(at the baseline)
  • Change from the baseline mean of the psychological distress measured by the Hospital Anxiety and Depression Scale at 4 weeks(after 4 weeks from the baseline)
  • Adherence to the to active and sham self-administered acupressure of the study.(throughout study completion, an average of 4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maha Gamal Ramadan Asal

Principle investgator

Alexandria University

研究点 (1)

Loading locations...

相似试验

Self- Administered Acupressure for Diarrhea... | 临床试验